Statistics for Long-term adherence and outcomes of oral Tyrosine Kinase Inhibitors for the treatment of CML in the US VHA medical system

Total visits

views
Long-term adherence and outcomes of oral Tyrosine Kinase Inhibitors for the treatment of CML in the US VHA medical system 127

Total visits per month

views
January 2024 0
February 2024 0
March 2024 0
April 2024 0
May 2024 0
June 2024 0
July 2024 1

File Visits

views
KREYS-DISSERTATION-2014.pdf(legacy) 130
KREYS-DISSERTATION-2014.pdf 108

Top country views

views
United States 130
China 20
Germany 15
France 12
United Kingdom 9
South Korea 6
Italy 5
Finland 4
India 3
Austria 2
Belgium 2
Spain 2
Sweden 2
Bangladesh 1
Brazil 1
Hong Kong SAR China 1
Ireland 1
Iran 1
Latvia 1
Moldova 1
North Macedonia 1
Malaysia 1
Netherlands 1
Nepal 1
New Zealand 1
Peru 1
Portugal 1
Romania 1
Singapore 1

Top city views

views
Boardman 16
Wilmington 15
Ashburn 10
Beijing 6
Woodbridge 5
Austin 4
Zhengzhou 4
Rome 3
Calcutta 2
Council Bluffs 2
Frankfurt am Main 2
Ghent 2
Kugayama 2
Nashville 2
Nutley 2
Pittsburgh 2
Sabadell 2
San Diego 2
Shenzhen 2
Stockholm 2
Tianjin 2
Addlestone 1
Atlanta 1
Auckland 1
Baxter 1
Bengaluru 1
Chicago 1
Clarkston 1
College Station 1
Des Moines 1
Dhaka 1
Dublin 1
Houston 1
Irving 1
Kathmandu 1
Kuala Lumpur 1
Lake Forest 1
Lima 1
Lisbon 1
Mountain View 1
Nagoya 1
Nanchang 1
Nijmegen 1
Nishinomiya 1
Nuremberg 1
Olalla 1
Philadelphia 1
Riga 1
Rugby 1
San Antonio 1
Seoul 1
Shijiazhuang 1
Singapore 1
São Paulo 1
Tehran 1
Washington 1
Winston Salem 1